Skip to main content

Want a detailed portfolio tracker?

CDIO
NASDAQ
$1.63

Cardio Diagnostics Holdings Inc (CDIO)

Cardio Diagnostics Holdings Inc (CDIO) is an innovative biotechnology company dedicated to improving cardiovascular health through advanced diagnostic solutions. By harnessing cutting-edge technology, CDIO provides healthcare professionals with essential tools for accurate assessment and effective management of cardiovascular diseases, ultimately enhancing patient outcomes. With a strong focus on personalized medicine, the company is strategically poised for substantial growth, representing a compelling investment opportunity for institutional investors aiming to leverage advancements in the evolving healthcare landscape.
Website: https://cdio.ai
Sector:
Healthcare
Industry:
Biotechnology
Target: $60 (+3580.98%)

Market Cap

$5.30M

P/B Ratio

0.60

Beta (5Y)

2.07

Price Chart

Valuation
Market Cap$5.30M
P/S319.80
P/B0.60
Profitability
Total Revenue (TTM)$17K
Gross Profit (TTM)$17K
EBITDA-$6.61M
Operating Margin-66598%
EPS-$3.34
Growth & Risk
Beta (5Y)2.07
Sharpe Ratio-0.09